chevron_leftBack
As of 24 April 2025, Diagnamed Holdings Corp. has a market cap of $1.81M USD, ranking #38053 globally and #2067 in Canada. It ranks #3867 in the Healthcare sector, and #209 in the Health Information Services industry.
Key Stats
Market Cap
$1.81MUSD
2.5M CAD
Enterprise Value
$1.72MUSD
2.39M CAD
Net Income (TTM)
-$487.33KUSD
-674.89K CAD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Health Information Services
CEO
Fabio Chianelli
open_in_new
Website
diagnamed.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -33% | -20% | -43% | 100% | -43% |
Upcoming Earnings
Earnings Date
Mon, May 26
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
DMED
Diagnamed Holdings Corp
ISIN: CA25245D1033
Shares Out.:
Shares Outstanding:
80.053M1
Shares Float:
69.761M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0300 CAD | |
|
DMED
Diagnamed Holdings Corp
ISIN: CA25245D1033
|
0.0250 CAD | |
|
DGNMF
Diagnamed Holdings Corp
ISIN: CA25245D1033
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0172 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. It focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders; and CERVAI, brain health and wellness AI solution. It has a collaboration agreement with EIREX for the development and commercialization of EIREX’s novel modular carbon-free technology that extracts hydrogen from water. Diagnamed Holdings Corp. is headquartered in Toronto, Canada.
